Sysmex (OTCMKTS:SSMXY) Shares Gap Down – Should You Sell?

Sysmex Corporation ADR (OTCMKTS:SSMXY)’s stock price gapped down prior to trading on Friday . The stock had previously closed at $9.4880, but opened at $9.03. Sysmex shares last traded at $9.3550, with a volume of 52,631 shares changing hands.

Analysts Set New Price Targets

A number of brokerages recently issued reports on SSMXY. Zacks Research upgraded shares of Sysmex from a “strong sell” rating to a “hold” rating in a research report on Thursday, August 14th. The Goldman Sachs Group raised Sysmex from a “hold” rating to a “buy” rating in a research note on Thursday, October 9th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, Sysmex presently has an average rating of “Moderate Buy”.

Sysmex Stock Performance

The company has a market cap of $5.79 billion, a PE ratio of 18.39 and a beta of 1.17. The stock’s 50 day simple moving average is $11.03 and its two-hundred day simple moving average is $13.86. The company has a quick ratio of 2.49, a current ratio of 3.37 and a debt-to-equity ratio of 0.12.

Sysmex (OTCMKTS:SSMXY) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. The business had revenue of $826.60 million during the quarter, compared to the consensus estimate of $880.80 million. Sysmex had a return on equity of 9.99% and a net margin of 9.32%. As a group, research analysts anticipate that Sysmex Corporation ADR will post 0.57 earnings per share for the current year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.